Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ross Muken currently holds 628,743 shares of SOPHiA GENETICS SA (SOPH), valued at approximately $0. This represents their equity stake as President.
Based on SEC Form 4 filings, Ross Muken has been a net neutral trader of SOPH stock. They have purchased $0 and sold $0 worth of shares.
Ross Muken's most recent insider trade was on Apr 2, 2026, when they sold 628,743 shares at $0.00 per share.
Ross Muken serves as President at SOPHiA GENETICS SA (SOPH). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Ross Muken holds the position of President at SOPHiA GENETICS SA, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Ross Muken has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Ross Muken was on Apr 2, 2026, when they purchased $0 worth of SOPH shares. This transaction involved 628,743 shares at N/A per share.
Ross Muken currently owns 628,743 shares of SOPHiA GENETICS SA (SOPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ross Muken's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ross Muken has 2 Form 4 filings on record as an insider at SOPHiA GENETICS SA.
Set alerts for Ross Muken and 40,000+ other insiders.